Check out our most popular compounded medications! Get Started
Bayview Pharmacy is pleased to present a specialized bladder irrigation formulation that includes neomycin 0.35 mg/ml, gentamicin 0.08 mg/ml, and polymyxin B 100 U/ml. This unique combination is specifically designed to address a range of bladder-related conditions, such as urinary tract infections, bladder infections, and other bacterial infections within the bladder.
The formulation combines the power of three potent antibiotics. Neomycin, an aminoglycoside antibiotic, functions by inhibiting bacterial protein synthesis, thereby preventing the bacteria from growing and multiplying. Gentamicin, another aminoglycoside antibiotic, works by disrupting the synthesis of bacterial cell walls, leading to bacterial cell death. Polymyxin B, a polypeptide antibiotic, disrupts the bacterial cell membrane, causing leakage of intracellular contents and cell death.
It is crucial for patients to adhere to their doctor's instructions regarding usage and not to exceed the recommended dosage. Potential side effects may include nausea, vomiting, and diarrhea. Patients experiencing any of these side effects should immediately consult their healthcare provider.
If you have any queries about this bladder irrigation formulation or any other compounding services provided by Bayview Pharmacy, please feel free to contact us. Our team is committed to assisting you in finding the most suitable treatment for your condition.
This compounded formulation of Neomycin 0.35 mg/ml, Gentamicin 0.08 mg/ml, and Polymyxin B 100 U/ml is specifically designed for bladder irrigation. It is typically used for therapeutic purposes such as flushing the bladder, delivering medication, or removing debris or blood clots from the bladder.
Neomycin, gentamicin, and polymyxin B are all antibiotics that work to combat bacterial infections. However, it is crucial to note that this formulation is not suitable for treating fungal infections. Patients should be aware that this formulation may cause side effects such as irritation or burning of the bladder, nausea, vomiting, and diarrhea.
Furthermore, this formulation may interact with other medications, including antacids, diuretics, and other antibiotics. Therefore, patients should inform their healthcare provider of any other medications they are currently taking before starting this bladder irrigation treatment. This is to ensure that there are no adverse reactions or interactions with other medications.
Healthcare providers prescribing this formulation should also be aware of its potential interactions with other medications and its possible side effects. They should closely monitor patients for any signs of adverse reactions or interactions to ensure the safety and effectiveness of the treatment.
If you have any questions or concerns about this formulation or its potential interactions, please do not hesitate to reach out to your healthcare provider for further information and guidance.
This compounded formulation of Neomycin 0.35 mg/ml, Gentamicin 0.08 mg/ml, and Polymyxin B 100 U/ml is specifically designed for bladder irrigation. It is typically used for the treatment of various urinary tract infections, including cystitis, pyelonephritis, and urethritis. The combination of these three antibiotics works synergistically to inhibit the growth of bacteria in the bladder, thereby reducing the symptoms of infection and preventing further bacterial multiplication.
The administration of this formulation is through a procedure known as bladder irrigation. In this process, a sterile solution containing the antibiotics is introduced into the bladder via a catheter. The solution is then allowed to remain in the bladder for a period of time, typically between 15 and 30 minutes. During this period, the antibiotics are absorbed into the bladder wall, where they begin to combat the bacteria present.
When using this formulation, it is crucial to adhere to the instructions provided by your healthcare provider. The dosage and frequency of administration will be determined based on the severity of the infection and the patient's individual needs. It is also recommended to consume plenty of fluids while using this formulation, as this aids in flushing out the bacteria and reducing the risk of further infection.
If you have any queries about this formulation or its mechanism of action, do not hesitate to ask. It is important to understand your treatment fully to ensure its effectiveness. Remember, the goal is to find the best treatment for your condition.
This compounded formulation of Neomycin 0.35 mg/ml, Gentamicin 0.08 mg/ml, and Polymyxin B 100 U/ml is specifically designed for bladder irrigation. It is dispensed in syringes for controlled and precise administration, typically used for therapeutic purposes such as flushing the bladder, delivering medication, or removing debris or blood clots from the bladder.
Moreover, this formulation can also be used to treat other conditions such as bacterial prostatitis, epididymitis, and urethritis. It can also be used to treat bladder infections caused by Mycobacterium tuberculosis, Pseudomonas aeruginosa, Enterococcus faecalis, Staphylococcus aureus, and Escherichia coli.
If you have any questions about the use of this formulation, please do not hesitate to reach out. We are here to provide you with the necessary information and guidance to ensure the best possible treatment outcomes.
This formulation is specifically designed for bladder irrigation, which is a therapeutic procedure used for flushing the bladder, delivering medication, or removing debris or blood clots from the bladder.
The active ingredients in this formulation are Neomycin 0.35 mg/ml, Gentamicin 0.08 mg/ml, and Polymyxin B 100 U/ml.
This formulation is dispensed in syringes for controlled and precise administration directly into the bladder.
This formulation can be used to treat a variety of bladder-related conditions, particularly those that may benefit from the flushing of the bladder or the removal of debris or blood clots.
While primarily designed for bladder irrigation, this formulation may also be used for other purposes as directed by a healthcare professional.
As with any medication, there may be potential side effects. It's important to discuss these with your healthcare provider before starting treatment.
Not everyone can use this formulation. It's important to discuss your medical history with your healthcare provider before starting treatment to ensure it's safe for you.
This formulation should be stored as directed by the pharmacist or healthcare provider, typically in a cool, dry place away from direct sunlight.
If you miss a dose, you should contact your healthcare provider for advice. Do not double up on doses unless instructed to do so.
Even if your symptoms improve, you should continue using this formulation as directed by your healthcare provider. Stopping treatment prematurely may lead to a recurrence of your symptoms.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NY, NJ, NH, and FL. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Instill into bladder
